226 related articles for article (PubMed ID: 30276310)
1. Targeting G protein-coupled receptor for pain management.
Li H; Wang R; Lu Y; Xu X; Ni J
Brain Circ; 2017; 3(2):109-113. PubMed ID: 30276310
[TBL] [Abstract][Full Text] [Related]
2. Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential.
Jiang BC; Liu T; Gao YJ
Pharmacol Ther; 2020 Aug; 212():107581. PubMed ID: 32450191
[TBL] [Abstract][Full Text] [Related]
3. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.
Szabo I; Chen XH; Xin L; Adler MW; Howard OM; Oppenheim JJ; Rogers TJ
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10276-81. PubMed ID: 12130663
[TBL] [Abstract][Full Text] [Related]
4. Constitutively active chemokine CXC receptors.
Han X
Adv Pharmacol; 2014; 70():265-301. PubMed ID: 24931199
[TBL] [Abstract][Full Text] [Related]
5. Chemokines as pain mediators and modulators.
White FA; Wilson NM
Curr Opin Anaesthesiol; 2008 Oct; 21(5):580-5. PubMed ID: 18784482
[TBL] [Abstract][Full Text] [Related]
6. Heterophilic chemokine receptor interactions in chemokine signaling and biology.
Kramp BK; Sarabi A; Koenen RR; Weber C
Exp Cell Res; 2011 Mar; 317(5):655-63. PubMed ID: 21146524
[TBL] [Abstract][Full Text] [Related]
7. Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation.
Grudzien P; Neufeld H; Ebe Eyenga M; Gaponenko V
Front Immunol; 2023; 14():1184014. PubMed ID: 37575219
[TBL] [Abstract][Full Text] [Related]
8. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.
Lee HJ; Song IC; Yun HJ; Jo DY; Kim S
World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647
[TBL] [Abstract][Full Text] [Related]
9. Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.
Pawlik K; Mika J
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570736
[TBL] [Abstract][Full Text] [Related]
10. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells.
Brack A; Rittner HL; Machelska H; Leder K; Mousa SA; Schäfer M; Stein C
Pain; 2004 Dec; 112(3):229-238. PubMed ID: 15561377
[TBL] [Abstract][Full Text] [Related]
11. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
[TBL] [Abstract][Full Text] [Related]
12. Regulation of chemokine activity by posttranslational modification.
Mortier A; Van Damme J; Proost P
Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
[TBL] [Abstract][Full Text] [Related]
13. CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy.
Bogacka J; Pawlik K; Ciapała K; Ciechanowska A; Mika J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555280
[TBL] [Abstract][Full Text] [Related]
14. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
15. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
[TBL] [Abstract][Full Text] [Related]
16. Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain.
Vincenzi M; Milella MS; D'Ottavio G; Caprioli D; Reverte I; Maftei D
Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330149
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine-immune interaction: regulation of inflammation via G-protein coupled receptors.
Verburg-van Kemenade BM; Van der Aa LM; Chadzinska M
Gen Comp Endocrinol; 2013 Jul; 188():94-101. PubMed ID: 23201149
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
[TBL] [Abstract][Full Text] [Related]
19. The Role of CXC Chemokines in Cancer Progression.
Wu T; Yang W; Sun A; Wei Z; Lin Q
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612163
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
